Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stobdan Kalon
Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB Among Treatment Failures
PLoS ONE
Multidisciplinary
Related publications
Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh
Journal of Tuberculosis Research
Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis
The Lancet Infectious Diseases
Infectious Diseases
Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis
The Lancet
Medicine
Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology